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Identity 
Other names: N-RAS (neuroblastoma RAS viral 
oncogene homolog) 
HGNC (Hugo): NRAS 
Location: 1p13 




Consists of seven exons, spread over 8 kb of genomic 
DNA. 
Transcription 
Inefficient processing of pre-mRNA reveals two  
different transcripts of 4.3 kb and 2 kb (see Fig), 
differing in the extension of the 3’ end of the smaller 
message; the longer transcript is probably a result of an 
RNA-extension through the termination site. 
Protein 
Description 





Anchored to the inner surface of the plasma membrane. 
 
 
Evolution of two N-ras mRNA transcripts the slightly differing consensus sequence of the poly A addition site (AATATA instead of 
AATAAA) leads to inefficient processing and to two different RNA transcripts; exons that encode protein are shown as black boxes, 
untranslated exons as white boxes; the upstream untranslated exon is indicated as exon -1.
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Analogously to other GTP-binding proteins (such as 
Translation Elongation Factor EFTu or signal 
transducing G-Proteins) RAS proteins are involved in 
signal transduction pathways. 
Homology 
Ras gene family is part of the ras superfamily including 
the mammalian RAS, RAL, RAC, RHO, RAP, and 
RAB gene families and the yeast homologs like SEC4 
and YPT1 genes; genes encode small monomeric 
proteins of low molecular mass (20-30 kDa) which 
share at least 30% homology to RAS proteins. 
Implicated in 
Tumor (frequency of N-RAS mutations); 
references in Full Bibliography 
Acute non lymphocytic leukemia and 
myelodysplasia (20-40%) 
Chronic myelogenous leukemia, acute 





Stomach (gastric tumors) (5%) 
Testis liver (0-15%) 
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